A new study highlights the under-reporting of racial and ethnic data from pivotal trials for drugs that have received approval in Europe, which perhaps is one reason trial diversity has been less in the public spotlight there.
Pivotal Trials For EU Approval Still Underrepresent Minorities, Study Finds
Roma, Europe’s Largest Minority, Not Represented At All
The study, by Tufts CSDD, also found that data on minority groups were frequently underreported, and in many cases numbers have not improved with time.
